EmmanuelleAndree DanielleSchindlerMDPhD

Headache

Neurology Service Attending, West Haven VA Medical Center; Assistant Professor of Neurology, Yale School of Medicine

Dr. Schindler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
950 Campbell Ave
West Haven, CT 06516
Phone+1 203-932-5711

Fax+1 203-937-3464

Psilocybin for the Treatment of Cluster Headache Start of enrollment: 2016 Dec 05
Completed
Phase 1
Psilocybin for the Treatment of Migraine Headache Start of enrollment: 2017 Nov 01
Completed
Phase 1
Effects of Psilocybin in Concussion Headache Start of enrollment: 2019 Mar 28
Terminated
Phase 1

PubMed

The Pain Gap: Epistemic Justice in Psychedelic Ethics.
Joanna Kempner, Emmanuelle A D Schindler
The American Journal of Bioethics. 2025-01-01
Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study.
Elizabeth K Seng, Mark J Burish, Brenda T Fenton, Emmanuelle A D Schindler, Bin Zhou
Headache. 2024-10-14
1 citations
Managing Cluster Headache in Patients with Medical, Psychiatric, and Surgical Comorbidities.
Mark J Burish, Alexander B Guirguis, Emmanuelle A D Schindler
Current Neurology and Neuroscience Reports. 2024-09-01

The Psychedelic Remedy for Chronic PainOctober 1st, 2022
Why Magic Mushrooms Are Emerging as Major Part of Public Discourse: What Science Is SayingSeptember 23rd, 2022
electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic HeadacheMay 4th, 2021
Join now to see all

Advanced Research FellowIn my fellowship at VA Connecticut Healthcare System, I developed and executed the first controlled human trials of psilocybin in headache disorders (and any neurological disorder).2016 - 2018
Graduate studentAs a graduate student at Drexel, I studied the neuropharmacology of 5-hydroxytryptamine (5-HT)2A receptor compounds, outlining biochemical and behavioral effects in the context of receptor binding and intracellular signaling.2005 - 2010